Companies & Industry »Company News»Company News Details
Company News Details

BSE   17 Dec 14 | 12:00 AM

1493.50 -36.25 (-2.37%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   17 Dec 14 | 12:00 AM

1496.75 -33.6 (-2.2%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 1,581.80 (-5.58%)
1 Month : Rs 1,539.15 (-2.97%)
1 Year : Rs 745.30 (100.39%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Sensex

Company Price Gain (%)
Sesa Sterlite200.853.50
O N G C342.752.16
St Bk of India302.052.08
Hindalco Inds.147.251.76
Tata Steel393.451.04

Online Portfolio

You can create Online Portfolio here using the below button.